
Moderna and MIT Announce Universal mRNA Vaccine Platform Neutralizing All Influenza and Coronavirus Strains
Moderna and MIT have announced the Phase 3 success of mRNA-pan-Cov-Flu, a universal mRNA vaccine utilizing mosaic nanoparticles to target conserved vi...
Read Full Story →




